XML 16 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Non-Controlling Interests
Balance, beginning of period at Dec. 31, 2022 $ 2,458.1 $ 1.2 $ 3,484.2 $ 3,868.5 $ (458.7) $ (4,447.9) $ 10.8
Balance, beginning of period (in shares) at Dec. 31, 2022   118,028,009          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 77.8     77.8      
Other comprehensive income (loss) 7.1       7.1    
Issuances under equity plans (8.6)   1.3     (9.9)  
Issuances under equity plans (in shares)   336,079          
Share-based compensation expense 5.1   5.1        
Repurchases of common stock (30.3)         (30.3)  
Noncontrolling interest transactions 0.2           0.2
Balance, end of period at Mar. 31, 2023 2,509.4 $ 1.2 3,490.6 3,946.3 (451.6) (4,488.1) 11.0
Balance, end of period (in shares) at Mar. 31, 2023   118,364,088          
Balance, beginning of period at Dec. 31, 2023 2,234.1 $ 1.2 3,514.9 3,813.0 (466.0) (4,639.8) 10.8
Balance, beginning of period (in shares) at Dec. 31, 2023   118,387,641          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 39.7     39.7      
Other comprehensive income (loss) (29.5)       (29.5)    
Issuances under equity plans (10.3)         (10.3)  
Issuances under equity plans (in shares)   420,210          
Share-based compensation expense 7.5   7.5        
Repurchases of common stock (50.3)         (50.3)  
Noncontrolling interest transactions (3.5)   (3.7)       0.2
Balance, end of period at Mar. 31, 2024 $ 2,187.7 $ 1.2 $ 3,518.7 $ 3,852.7 $ (495.5) $ (4,700.4) $ 11.0
Balance, end of period (in shares) at Mar. 31, 2024   118,807,851